INDICATIONS AND USAGE TRYPTYR (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).

(Reuters) -Eye-care drugmaker Alcon said on Wednesday that the U.S. Food and Drug Administration has approved its treatment ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Additional risk factors include contact lens wear, previous eye surgery, residence in dry climates, excessive screen time, ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

A new randomized controlled trial reveals that topical timolol significantly improves the appearance of post-mammoplasty ...

Glaucoma can cause irreversible blindness and with early diagnosis and treatment key, a highly advanced new micro-stent surgery now available ...